Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
A novel non-invasive method for using carbon-13 magnetization transfer effects to determine and evaluate in vivo aspartate transaminase (AST) activity and levels in an organ, as a biomarker of disease and certain neurological disorders. More
Related Reports
Market Research Reports provided by reports.iptechex.com
Dec 2010 - 25 pages - $500
Jul 2011 - 52 pages - $2,000
Apr 2011 - 39 pages - $500
Aug 2011 - 41 pages - $500
May 2011 - 39 pages - $500
Mar 2011 - 49 pages - $500
Apr 2011 - 53 pages - $500
Mar 2011 - 60 pages - $2,000
Mar 2011 - 37 pages - $1,000
Aug 2011 - 76 pages - $500
Your selection
Browse By
- Industry sector
- Antibody-based diagnostics
- Biomarker-based diagnostics
- CAT
- Genetic diagnostics
- Imaging
- MRI
- Nuclear medicine
- Other
- Self-test systems
- Supplies
- Test systems
- Ultrasound
- X-ray
- Development phase
- Early Stage
- Preclinical
- Phase I
- Phase I/II
- Phase II
- Phase III
- Phase III/IV
- Preregistration
- Registered
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us